Discovery and evaluation of enantiopure 9H-pyrimido[4,5‐b]indoles as nanomolar GSK‐3β inhibitors with improved metabolic stability

MLA

Stanislav Andreev, et al. Discovery and Evaluation of Enantiopure 9H-Pyrimido[4,5‐b]Indoles as Nanomolar GSK‐3β Inhibitors with Improved Metabolic Stability. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....f96ca3718f42f0614b0557b3c394d9ce&authtype=sso&custid=ns315887.

APA

Stanislav Andreev, Tatu Pantsar, Ahmed El-Gokha, Francesco Ansideri, Mark Kudolo, Débora Bublitz Anton, Giulia Sita, Jenny Romasco, Christian Geibel, Michael Lämmerhofer, Márcia Ines Goettert, Andrea Tarozzi, Stefan A. Laufer, & Pierre Koch. (2020). Discovery and evaluation of enantiopure 9H-pyrimido[4,5‐b]indoles as nanomolar GSK‐3β inhibitors with improved metabolic stability.

Chicago

Stanislav Andreev, Tatu Pantsar, Ahmed El-Gokha, Francesco Ansideri, Mark Kudolo, Débora Bublitz Anton, Giulia Sita, et al. 2020. “Discovery and Evaluation of Enantiopure 9H-Pyrimido[4,5‐b]Indoles as Nanomolar GSK‐3β Inhibitors with Improved Metabolic Stability,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....f96ca3718f42f0614b0557b3c394d9ce&authtype=sso&custid=ns315887.